BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • Blog
    • Interviews
  • News
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Exosomes
  • CAR-T
  • Cord Blood
  • Shop
    • Products
    • Submit PR
    • Advertise
  • About
    • Testimonials
    • Story
    • Guarantee
    • Contact
  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • Stem Cell News
    • Interviews
  • COVID-19
  • Shop
  • Submit PR
  • Company
    • Advertise
    • Testimonials
    • Story
    • Job Posts
    • Guarantee
    • Privacy Policy
    • Contact
Home » “iPSCs, The Next Decade”, a Webinar Exploring the Next Decade of iPSC Innovation
iPSCs, the Next Decade

“iPSCs, The Next Decade”, a Webinar Exploring the Next Decade of iPSC Innovation

October 20, 2016 By Cade Hildreth (CEO) Leave a Comment

iPSC Webinar, the Next DecadeCell Press Webinar – “iPSCs: The Next Decade”

October 25, 2016 – 12:00 PM EST

Groundbreaking experimentation in 2006 led to the introduction of induced pluripotent stem cells (iPSCs). These are adult cells which are isolated and then transformed into embryonic-like stem cells through the manipulation of gene expression, as well as other methods. Research and experimentation using mouse cells by Shinya Yamanaka’s lab at Kyoto University in Japan was the first instance in which there was successful generation of iPSCs.

Discover class-defining bioproduction tools.

In 2007, a series of follow-up experiments was done at Kyoto University in which human adult cells were transformed into iPSCs. Nearly simultaneously, a research group led by James Thomson at the University of Wisconsin-Madison accomplished the same feat of deriving iPSC lines from human somatic cells.

In the 10 years since their discovery, induced pluripotent stem cells have transformed our toolkit for studying human development and disease. As the field enters its next decade, a new wave of innovative technologies, such as CRISPR/Cas9-based genome editing, organoid culture, and single-cell omics, have converged with iPSCs to yield new insights for their use in stem cell engineering and therapeutic discovery.

bitbio

Featured Speakers

Join us on October 25th at 12:00 PM EST for exciting presentations from our speakers Guo-Li Ming of Johns Hopkins University and Charles Gersbach of Duke University on how these novel advanced technologies are being applied in iPSCs to generate better models for studying and treating human disease.

Guo-Li Ming - iPSC SpeakerCharles Gersbach - iPSC SpeakerSteve Mao - iPSC Moderator

Pluristyx

Registration Details

Titled “iPSCs: The Next Decade,” full registration details for the webinar are included below.

Date/Time: October 25, 2016 at 12:00 PM EST (Check the time in your country)

Speakers:

iPSC-derived cardiomyocte therapy
  • Guo-Li Ming, Professor of Neuroscience, Johns Hopkins University
  • Charles Gersbach, Professor, Biomedical Engineering, Duke University

Free Event: Registration is free and registrants can also access the webinar on demand after Oct 25.

For additional details or to register for the live webinar, click here.

4.9/5 - (34 votes)

Filed Under: iPS Cells, Stem Cell News, Stem Cells Tagged With: CellPress, Cellular Dynamics International, iPSC, webinar

Related

About Cade Hildreth (CEO)

Cade Hildreth is the Founder of BioInformant.com, the world's largest publisher of stem cell industry news. Cade is a media expert on stem cells, recently interviewed by the Wall Street Journal, Los Angeles Business Journal, Xconomy, and Vogue Magazine. 

Tell Us What You Think! Cancel reply

Nanocellect

Marathon Products

Let’s Get Social

  • Facebook
  • Twitter
  • LinkedIn
  • Pinterest
  • Instagram
Menu
  • Blog
  • Stem Cell News
    • Press Releases
  • Stem Cells
    • HSCs
    • iPS Cells
    • MSCs
    • Neural Stem Cells
    • Adipose SCs
  • Exosomes
  • Cell Therapy
    • CAR-T
  • Cord Blood
  • Interviews

Cart

Featured Posts

Cord Blood Market Segmentation

Cord Blood Market Segmentation – Biobanking, HSCT, Cellular Therapy, Genetic Manipulation, & Research Tools

CAR-T Companies

CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide

Who discovered stem cells?

Who Discovered Stem Cells? The Answers Revealed

My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Privacy and Terms

Copyright © 2022 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: Info@BioInformant.com | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.